ENTITY
AstraZeneca

AstraZeneca (AZN LN)

203
Analysis
Health Care • United Kingdom
AstraZeneca is a Swedish-British multinational pharmaceutical and biotechnology company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was formed in 1999 through the merger of Astra AB and Zeneca Group PLC and is headquartered in Cambridge, UK.
more
•01 Oct 2021 00:00•Exchange-sponsored

SGX Asia Currencies and Commodities Insights

SGX Asia Currencies Insights Yuan stability should continue given risks from China’s rapidly slowing economy and ongoing financial stability...

Share
bullish•Pfizer
•12 Apr 2021 00:00•Exchange-sponsored

SGX Asia Currencies and Commodities Insights

By Macro Hive   SGX Asia Currencies Insights CNH has traded well against most currencies, and flows remain strong. Therefore, recent USD/CNH...

Share
bullish•AstraZeneca
•23 Feb 2021 22:39•Issuer-paid

Video: Oxford Biomedica – executive interview

Why are investors buying into Oxford Biomedica (LN:OXB)? In this interview, BBC broadcaster Vivienne Parry OBE asks CEO John Dawson why Oxford...

Share
x